The global molecular diagnostics market size is expected to reach USD 17.97 billion by 2030, and expanding at a CAGR of 4.5% from 2024 to 2030, according to a recent study by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.
Molecular Diagnostics Market Report Highlights
· The reagents segment dominated the market and accounted for a share of 62.2% of the global revenue in 2023. It is expected to maintain its dominance throughout the forecast years owing to its wide application scope in research & clinical settings and increasing adoption of novel tests.
· The polymerase chain reaction technology segment accounted for the largest revenue share in 2023. This is attributed to its use in detecting COVID-19 and other infectious diseases.
· The infectious diseases segment accounted for the largest revenue share in 2023. The increased usage of molecular, particularly PCR tests, for diagnosing COVID-19 has increased the segment share significantly.
· The central laboratories segment dominated the industry in 2023 owing to high procedure volumes for COVID testing and other healthcare indications in central laboratories.
· North America dominated the market and accounted for a 39.3% share in 2023. This is attributed to the rising epidemiology of infectious as well as chronic diseases, thus, encouraging companies to introduce novel molecular diagnostic tests, thereby boosting market growth.
· Asia Pacific is anticipated to exhibit significant growth from 2024 to 2030 owing to increased market penetration, initiatives of local market players to increase the adoption of novel diagnostic technologies, and high unmet market needs.
For More Details or Sample Copy please visit link @: Molecular Diagnostics Market Report
Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.
Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.
Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.
Gain deeper insights on the market and receive your free copy with TOC now @: https://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market/request/rs15
We segmented the global molecular diagnostics market report based on product, technology, application, test location, and region.
Molecular Diagnostics Product Outlook (Revenue, USD Million, 2018 – 2030)
· Instruments
· Reagents
· Others
Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018 – 2030)
· Polymerase chain reaction (PCR)
o By Type
o Multiplex PCR
o Other PCR
o By Product
o Instruments
o Reagents
o Others
· In Situ Hybridization (ISH)
o Instruments
o Reagents
o Others
· Isothermal Nucleic Acid Amplification Technology (INAAT)
o Instruments
o Reagents
o Others
· Chips and Microarrays
o Instruments
o Reagents
o Others
· Mass Spectrometry
o Instruments
o Reagents
o Others
· Sequencing
o Instruments
o Reagents
o Others
· Transcription Mediated Amplification (TMA)
o Instruments
o Reagents
o Others
· Others
o Instruments
o Reagents
o Others
Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018 – 2030)
· Oncology
o Breast Cancer
o Prostate Cancer
o Colorectal Cancer
o Cervical Cancer
o Kidney Cancer
o Liver Cancer
o Blood Cancer
o Lung Cancer
o Other Cancer
· Pharmacogenomics
· Infectious Diseases
o Methicillin-resistant Staphylococcus Aureus (MRSA)
o Clostridium Difficile
o Vancomycin-resistant Enterococci (VRE)
o Carbapenem-resistant Bacteria
o Flu
o Respiratory Syncytial Virus (RSV)
o Candida
o Tuberculosis and Drug-resistant TBA
o Meningitis
o Gastrointestinal Panel Testing
o Chlamydia
o Gonorrhea
o HIV
o Hepatitis C
o Hepatitis B
o Other Infectious Diseases
· Genetic Testing
o Newborn Screening
o Predictive and Presymptomatic Testing
o Other Genetic Testing
· Neurological Disease
· Cardiovascular Disease
· Microbiology
· Others
Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2018 – 2030)
· Point of Care
· Self-test or OTC
· Central Laboratories
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/checkout/select-license/molecular-diagnostics-market
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
DNAwise test includes a varied range of parameters, including health risks that help you in knowing yourself more and create an action plan for your wellbeing.
Are you following the same diet and exercise as everyone else but not getting the desired results?
Get the Genes2Fit test, a new age genetic profile that provides you personalized insight into your DNA.
The comprehensive panel offers you personalized information on significant lifestyle traits, exercise plans, metabolites, nutrient requirements, eating behaviour, food reaction, body, and weight.
Become the best version of yourself by following a health and fitness solution unique to your DNA profile.
Call Now for Booking 18001214030 | [email protected]
